Tailored pre-procedural management and four-clip trans-catheter edge-to-edge repair procedure to efficiently treat torrential tricuspid regurgitation: a case report.
Case report
Management
Percutaneous valve repair
Tricuspid regurgitation
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
01
04
2023
revised:
15
09
2023
accepted:
27
09
2023
medline:
16
10
2023
pubmed:
16
10
2023
entrez:
16
10
2023
Statut:
epublish
Résumé
The use of trans-catheter treatment for tricuspid regurgitation (TR) is currently increasing, especially trans-catheter edge-to-edge repair (TEER). However, patients with very large coaptation gaps are usually considered not eligible for this treatment. We present the case of an 87-year-old man with symptomatic [New York Heart Association (NYHA) functional Class IV, right-sided heart failure signs] isolated torrential TR due to chronic atrial fibrillation who was initially considered not eligible for a tricuspid valve (TV) TEER because of a very large coaptation gap. A leadless pacemaker was implanted, and the patient received high doses of intravenous diuretics at home during 2 months. After heart team discussion, he was then considered suitable for a TEER procedure. A 'zipping' technique was performed, with the implantation of four TriClip devices, based on the anatomy of the TV and guided by fluoroscopy and bi- and tri-dimensional trans-oesophageal echocardiography, allowing an excellent procedural result (mild TR and mean TV gradient = 1 mmHg). At 6 months, TR was still mild, the patient reported a remarkable improvement (NYHA I, no heart failure signs), and 6-min walk test increased from 260 to 375 m. This case underscores the need for heart valve centres with dedicated and experienced teams and networks of care to adequately manage patients with severe TR from pre-procedural choice of cardiac pacing type and optimization of diuretic therapy to customized interventions with appropriate number and location of clips according to the anatomy of the valve and the mechanism of TR, guided by high-quality bi- and tri-dimensional echocardiography.
Sections du résumé
Background
UNASSIGNED
The use of trans-catheter treatment for tricuspid regurgitation (TR) is currently increasing, especially trans-catheter edge-to-edge repair (TEER). However, patients with very large coaptation gaps are usually considered not eligible for this treatment.
Case summary
UNASSIGNED
We present the case of an 87-year-old man with symptomatic [New York Heart Association (NYHA) functional Class IV, right-sided heart failure signs] isolated torrential TR due to chronic atrial fibrillation who was initially considered not eligible for a tricuspid valve (TV) TEER because of a very large coaptation gap. A leadless pacemaker was implanted, and the patient received high doses of intravenous diuretics at home during 2 months. After heart team discussion, he was then considered suitable for a TEER procedure. A 'zipping' technique was performed, with the implantation of four TriClip devices, based on the anatomy of the TV and guided by fluoroscopy and bi- and tri-dimensional trans-oesophageal echocardiography, allowing an excellent procedural result (mild TR and mean TV gradient = 1 mmHg). At 6 months, TR was still mild, the patient reported a remarkable improvement (NYHA I, no heart failure signs), and 6-min walk test increased from 260 to 375 m.
Discussion
UNASSIGNED
This case underscores the need for heart valve centres with dedicated and experienced teams and networks of care to adequately manage patients with severe TR from pre-procedural choice of cardiac pacing type and optimization of diuretic therapy to customized interventions with appropriate number and location of clips according to the anatomy of the valve and the mechanism of TR, guided by high-quality bi- and tri-dimensional echocardiography.
Identifiants
pubmed: 37841046
doi: 10.1093/ehjcr/ytad475
pii: ytad475
pmc: PMC10568525
doi:
Types de publication
Case Reports
Langues
eng
Pagination
ytad475Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.
Déclaration de conflit d'intérêts
Conflict of interest: Julien Dreyfus and Mohammed Nejjari are proctors for Abbott.
Références
Eur Heart J Cardiovasc Imaging. 2017 Dec 1;18(12):1342-1343
pubmed: 28977455
J Am Coll Cardiol. 2022 Dec 13;80(24):2289-2298
pubmed: 36480971
EuroIntervention. 2021 Nov 19;17(10):791-808
pubmed: 34796878
Eur Heart J. 2019 Feb 1;40(5):476-484
pubmed: 30351406
Eur J Heart Fail. 2020 Oct;22(10):1803-1813
pubmed: 32367642
JACC Cardiovasc Imaging. 2021 Jul;14(7):1299-1305
pubmed: 33744134
Eur Heart J Cardiovasc Imaging. 2021 Jan 22;22(2):196-202
pubmed: 32783057
Eur Heart J. 2023 Aug 25;:
pubmed: 37624856
JACC Cardiovasc Imaging. 2019 Mar;12(3):433-442
pubmed: 30121261
Int J Cardiol. 2022 Oct 15;365:69-77
pubmed: 35853499
Eur Heart J. 2022 Feb 12;43(7):654-662
pubmed: 34586392
Am J Cardiol. 2020 Oct 1;132:119-125
pubmed: 32741538
JACC Case Rep. 2020 Jun 17;2(6):862-865
pubmed: 34317368
N Engl J Med. 2023 May 18;388(20):1833-1842
pubmed: 36876753